Tower Research Capital (TRC)’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.05M | Buy |
|
|||||
|
2025
Q1 | $911 | Sell |
|
|||||
|
2024
Q4 | $2.98M | Buy |
|
|||||
|
2024
Q3 | $2.78M | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $325K | Sell |
|
|||||
|
2023
Q4 | $1.85M | Buy |
|
|||||
|
2023
Q3 | $1.32M | Buy |
|
|||||
|
2023
Q2 | $592K | Sell |
|
|||||
|
2023
Q1 | $2.29M | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $3.48M | Buy |
|
|||||
|
2022
Q2 | $371K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $588K | Sell |
|
|||||
|
2021
Q3 | $1.3M | Sell |
|
|||||
|
2021
Q2 | $2.17M | Buy |
|
|||||
|
2021
Q1 | $905K | Buy |
|
|||||
|
2020
Q4 | $65K | Buy |
|
|||||
|
2020
Q3 | $32K | Sell |
|
|||||
|
2020
Q2 | $827K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $893K | Buy |
|
|||||
|
2019
Q3 | $89K | Sell |
|
|||||
|
2019
Q2 | $2.46M | Buy |
|
|||||
|
2019
Q1 | $689K | Buy |
|
|||||
|
2018
Q4 | $305K | Buy |
|
|||||
|
2018
Q3 | $253K | Sell |
|
|||||
|
2018
Q2 | $1.61M | Buy |
|
|||||
|
2018
Q1 | $1.04M | Sell |
|
|||||
|
2017
Q4 | $1.81M | Buy |
|
|||||
|
2017
Q3 | $27K | Sell |
|
|||||
|
2017
Q2 | $980K | Buy |
|
|||||
|
2017
Q1 | $16K | Buy |
|
|||||
|
2016
Q4 | $9K | Sell |
|
|||||
|
2016
Q3 | $25K | Buy |
|